🇺🇸 FDA
Patent

US 11098082

Antigenic peptides and uses thereof for diagnosing and treating autism

granted A61KA61K9/0019A61P

Quick answer

US patent 11098082 (Antigenic peptides and uses thereof for diagnosing and treating autism) held by The Regents of the University of California expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K9/0019, A61P, A61P25/00